Zu, Rui
Yu, Zhen http://orcid.org/0000-0003-1169-5955
Zhao, Jing
Lu, Xiaojuan
Liang, Wei
Sun, Le
Si, Chenfang
Zhu, Kezhou
Zhang, Tian
Li, Ganquan
Zhang, Mengmeng
Zhang, Yaoyang http://orcid.org/0000-0001-5363-9834
Liu, Nan
Yuan, Junying http://orcid.org/0000-0003-2405-6036
Shan, Bing
Funding for this research was provided by:
Ministry of Science and Technology of the People’s Republic of China (2016YFA0501900)
National Natural Science Foundation of China (31530041, 21837004, 91849204, 92049303 and 31701210, 91849109)
Science and Technology Commission of Shanghai Municipality (2019SHZDZX02)
Natural Science Foundation of Shanghai (18JC1420500)
the Strategic Priority Research Program of the Chinese Academy of Sciences
Article History
Received: 27 April 2021
Revised: 13 September 2021
Accepted: 23 September 2021
First Online: 23 October 2021
Competing interests
: JY is a consultant for Denali Therapeutics and Sanofi. The other authors declare no competing interests.
: This study does not involve human participants, human data or human tissue, thus there is no requirement for ethical approval.